Department of Defense (DoD) Pharmacy Enterprise Operations Update

February 26, 2020

Target Audience

This activity provides continuing education for pharmacists and pharmacy technicians. A certificate of attendance is available for other attendees.

Learning Objectives

  1. Outline the DoD LOT population, including incidence and prevalence trends from 2007-2017 and major demographic, geographic, service-level, and clinical characteristics from the 2017 LOT population.
  2. Describe the opioid-related risk factors in the DoD LOT population, including risk factor trends from 2007-2017, demographic, geographic, and service-level factors associated with being high-risk, and a comparison of risk score calculators in determining high-risk.
  3. Identify the effect of the CDC and VA/DoD guidelines on the proportion of LOT patients with >90 MEDD and the proportion of LOT patients with concomitant benzodiazepines.
  4. Analyze the mission and vision & organization and programs of DHA Immunization Health care.
  5. Comprehend the role of the IHS in your region.
  6. Summarize the Continuous Quality Immunization Improvement Process (CQIIP) customer tool process, TSMP as it relates to vaccines, and the vaccine redistribution process.
  7. Recognize which patients are eligible for Non-Formulary medications.
  8. Discuss strategies to empower pharmacy staff to implement policies.
  9. Discover how the provider order entry near miss documentation was internalized into the pharmacy prescription review process.
  10. Evaluate how the data was collected, analyzed, and utilized to modify the provider order entry process and improve medication safety.
  11. Demonstrate how the SharePoint based analytics platform allows for vertical and horizontal transparency of data across our organization.
  12. Compare and discuss updates to the uniform formulary, including previous Pharmacy & Therapeutics (P&T) meeting clarifications, recent P&T drug class reviews, and placement of newly FDA-approved drugs.
  13. Explain new changes to the current prior authorization (PA) criteria and utilization management (UM) updates, such as medication quantity limits (QLs) and medications added as line-extensions.
Course summary
Available credit: 
  • 1.75 ACPE Pharmacist
    UAN JA4008136-0000-20-051-L04-P
    No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge based activity will provide a maximum of 1.75 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
  • 1.75 ACPE Pharmacy technician
    UAN JA4008136-0000-20-051-L04-T
    No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge based activity will provide a maximum of 1.75 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
  • 1.75 Certificate of Attendance
  • 1.75 IPCE
    This activity was planned by and for the healthcare team, and learners can receive up to 1.75 Interprofessional Continuing Education (IPCE) credits for learning and change. In support of improving patient care, this activity has been planned and implemented by DHA J-7 CEPO. DHA J-7 CEPO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), the American Academy of Physician Assistants (AAPA), the Association of Regulatory Boards of Optometry's Council on Optometric Practitioner Education (ARBO/COPE), the American Psychological Association (APA), and the Association of Social Work Boards (ASWB) to provide continuing education for the health care team.
Course opens: 
01/29/2020
Course expires: 
03/11/2020
Event starts: 
02/26/2020 - 13:00
Event ends: 
02/26/2020 - 14:45
San Antonio, TX
United States

Dial-In Information

1-800-369-2184 (OCONUS)
1-517-308-9366 (CONUS)
Passcode: 5817688

Webinar Link

DCS Link

https://carepoint.health.mil/SitePages/Detail.aspx?detailId=6958
 
  • Please use dial-in information to access sound for the Webinar
  • Please select “Listen Only” to join DCS and mute your microphones
  • The operator will provide information on how to open microphones for attendees to ask questions

Disclosure

  • DHA J-7 staff, Planning Committee Members and reviewers have no financial or non-financial interest to disclose. All faculty members have no financial or non-financial interest to disclose.

Available Credit

  • 1.75 ACPE Pharmacist
    UAN JA4008136-0000-20-051-L04-P
    No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge based activity will provide a maximum of 1.75 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
  • 1.75 ACPE Pharmacy technician
    UAN JA4008136-0000-20-051-L04-T
    No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge based activity will provide a maximum of 1.75 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
  • 1.75 Certificate of Attendance
  • 1.75 IPCE
    This activity was planned by and for the healthcare team, and learners can receive up to 1.75 Interprofessional Continuing Education (IPCE) credits for learning and change. In support of improving patient care, this activity has been planned and implemented by DHA J-7 CEPO. DHA J-7 CEPO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), the American Academy of Physician Assistants (AAPA), the Association of Regulatory Boards of Optometry's Council on Optometric Practitioner Education (ARBO/COPE), the American Psychological Association (APA), and the Association of Social Work Boards (ASWB) to provide continuing education for the health care team.
Please login or register to take this course.